SEC Form 4 · accession 0001250853-15-000110

IOVANCE BIOTHERAPEUTICS, INC. · IOVA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President and CEO · Director

Period of report

Feb 28, 2015

Accepted (ET)

Dec 30, 2015 · 6:57 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001425205

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Feb 28, 2015	M	40,000	$0.00	A	200,555	D
Common Stock	Feb 28, 2015	F	23,988	$8.98	D	176,567	D
Common Stock	holding	—	—		—	47,000	I	By Spouse

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock^F2	$0.00	Feb 28, 2015	M	40,000	D	—	—	Common Stock	40,000	160,000	D
Stock Option (right to buy)^F3	$7.58	Dec 28, 2015	A	58,939	A	—	Dec 27, 2015	Common Stock	58,939	58,939	D

F1Includes 40,000 shares of restricted stock that vested on 2/28/15 and 160,000 shares of restricted stock subject to forfeiture.
F2On February 5, 2014, the Reporting Person was granted 200,000 shares of restricted stock, which vested as to 40,000 shares on February 28, 2015 and will vest as to 60,000 shares on February 28, 2016 and as to 100,000 shares on February 28, 2017, provided the Reporting Person is still providing services to the Issuer on the respective dates.
F3One third of the shares underlying the option shall vest on December 28, 2016; and the remaining shares shall vest in eight equal quarterly installments over the next two years after the first anniversary of the grant date of December 28, 2015, provided the Reporting Person is still providing services to the Issuer on the respective dates.